메뉴 건너뛰기




Volumn 67, Issue 3, 2004, Pages 555-560

Feasibility of using half-life multipliers to estimate extended withdrawal intervals following the extralabel use of drugs in food-producing animals

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 2142772604     PISSN: 0362028X     EISSN: None     Source Type: Journal    
DOI: 10.4315/0362-028X-67.3.555     Document Type: Article
Times cited : (21)

References (12)
  • 1
    • 0030849390 scopus 로고    scopus 로고
    • The withdrawal time estimation of veterinary drugs: A nonparametric approach
    • Concordet, D., and P. L. Toutain. 1997. The withdrawal time estimation of veterinary drugs: a nonparametric approach. J. Vet. Pharmacol. Ther. 20:374-379.
    • (1997) J. Vet. Pharmacol. Ther. , vol.20 , pp. 374-379
    • Concordet, D.1    Toutain, P.L.2
  • 2
    • 0030825729 scopus 로고    scopus 로고
    • The withdrawal time estimation of veterinary drugs revisited
    • Concordet, D., and P. L. Toutain. 1997. The withdrawal time estimation of veterinary drugs revisited. J. Vet. Pharmacol. Ther. 20:380-386.
    • (1997) J. Vet. Pharmacol. Ther. , vol.20 , pp. 380-386
    • Concordet, D.1    Toutain, P.L.2
  • 3
    • 0033781329 scopus 로고    scopus 로고
    • Withdrawal time estimation of veterinary drugs: Extending the range of statistical methods
    • Fisch, R. D. 2000. Withdrawal time estimation of veterinary drugs: extending the range of statistical methods. J. Vet. Pharmacol. Ther. 23:159-162.
    • (2000) J. Vet. Pharmacol. Ther. , vol.23 , pp. 159-162
    • Fisch, R.D.1
  • 4
    • 0036979081 scopus 로고    scopus 로고
    • Extrapolated withdrawal-interval estimator (EWE) algorithm: A quantitative approach to establishing extralabel withdrawal times
    • Martin-Jimenez, T., R. E. Baynes, A. L. Craigmill, and J. E. Riviere. 2002. Extrapolated withdrawal-interval estimator (EWE) algorithm: a quantitative approach to establishing extralabel withdrawal times. Regul. Toxicol. Pharmacol. 36:131-137.
    • (2002) Regul. Toxicol. Pharmacol. , vol.36 , pp. 131-137
    • Martin-Jimenez, T.1    Baynes, R.E.2    Craigmill, A.L.3    Riviere, J.E.4
  • 5
    • 0026022862 scopus 로고
    • Pharmacologic principles of residue avoidance for veterinary practitioners
    • Riviere, J. E. 1991. Pharmacologic principles of residue avoidance for veterinary practitioners. J. Am. Vet. Med. Assoc. 198:809-816.
    • (1991) J. Am. Vet. Med. Assoc. , vol.198 , pp. 809-816
    • Riviere, J.E.1
  • 6
    • 0032185591 scopus 로고    scopus 로고
    • Primer on estimating withdrawal times after extralabel drug use
    • Riviere, J. E., A. I. Webb, and A. L. Craigmill. 1998. Primer on estimating withdrawal times after extralabel drug use. J. Am. Vet. Med. Assoc. 213:966-968.
    • (1998) J. Am. Vet. Med. Assoc. , vol.213 , pp. 966-968
    • Riviere, J.E.1    Webb, A.I.2    Craigmill, A.L.3
  • 7
    • 85039537373 scopus 로고
    • U.S. Food and Drug Administration. 1993. Freedom of Information summary NADA 013.123. Available at: http://www.fda.gov/cvm/efoi/section1/012123s063093. html. Accessed 2 May 2003.
    • (1993) Freedom of Information Summary NADA 013.123
  • 9
    • 84956678101 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. 1996. Freedom of Information summary NADA 141-063. Available at: http://www.fda.gov/cvm/efoi/section2/141063053196. html. Accessed 2 May 2003.
    • (1996) Freedom of Information Summary NADA 141-063
  • 10
    • 84871159199 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. 1997. Freedom of Information summary NADA 113-232. Available at: http://www.fda.gov/cvm/efoi/section1/113232s042397. html. Accessed 2 May 2003.
    • (1997) Freedom of Information Summary NADA 113-232
  • 11
    • 85039532507 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. 1998. Freedom of Information summary NADA 141-077. Available at: http://www.fda.gov/cvm/efoi/section2/141077012898. html. Accessed 2 May 2003.
    • (1998) Freedom of Information Summary NADA 141-077
  • 12
    • 85039515343 scopus 로고    scopus 로고
    • U.S. Food and Drug Administration. 2002. Freedom of Information summary NADA 141-207. Available at: http://www.fda.gov/cvm/efoi/section2/141077012898. html. Accessed 2 May 2003.
    • (2002) Freedom of Information Summary NADA 141-207


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.